Why one expert calls FTC's Express Scripts settlement a missed opportunity

February 11, 2026 at 07:00 PM
Share & Print
Pharma/PBMs
NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected].

Related Stories

Specialty drug costs expected to jump 32% by 2028, PSG finds Drug formulary rejections jump 67% Employers, PBMs face heightened regulatory scrutiny under new federal laws How celebs like Tom Brady and Lady Gaga are reshaping employee benefits  93% of uncovered employees would start GLP-1s if reimbursed GLP-1s are getting cheaper: Now is the time to act